James Daniel Guylain Priour
Geen lopende functies
Profiel
James Daniel Guylain Priour worked as a General Manager in Hungary for Bristol Myers Squibb Co. and as a Sales Manager for Procter & Gamble Co. He also worked as the Chief Commercial Officer for Zymeworks BC, Inc. from 2021 to 2022, and as the Head-General Medicine for Amgen France.
Additionally, he worked as a General Manager for Amgen Australia Pty Ltd.
Priour holds an MBA from NEOMA Business School.
Eerdere bekende functies van James Daniel Guylain Priour
Bedrijven | Functie | Einde |
---|---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Corporate Officer/Principal | 19-01-2022 |
Amgen Australia Pty Ltd. | Corporate Officer/Principal | - |
Amgen France | Corporate Officer/Principal | - |
BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | - |
PROCTER & GAMBLE COMPANY | Sales & Marketing | - |
Opleiding van James Daniel Guylain Priour
NEOMA Business School | Masters Business Admin |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
PROCTER & GAMBLE COMPANY | Consumer Non-Durables |
Bedrijven in privébezit | 3 |
---|---|
Zymeworks BC, Inc.
Zymeworks BC, Inc. BiotechnologyHealth Technology Zymeworks BC, Inc. is a clinical-stage biopharmaceutical company engaged in the discovery, development, and commercialization of biotherapeutics. Its product, ZW25 and ZW49, are a bispecific antibody that cans two non-overlapping epitopes. The company was founded by Anthony Fejes, J. Haig deB Farris, Nick Bedford, Ali Tehrani and Andrew S. Wright on September 8, 2003 and is headquartered in Vancouver, Canada. | Health Technology |
Amgen France | |
Amgen Australia Pty Ltd. |